FC
CNMD icon

Fairpointe Capital’s CONMED CNMD Stock Holding History

Fairpointe Capital’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$355K Buy
2,715
+9
+0.3% +$1.08K 0.54% 52
2020
Q4 		$303K Hold
2,706
– – 0.06% 67
2020
Q3 		$213K Buy
+2,706
New +$221K 0.03% 73

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fairpointe Capital's CNMD Position: Q1 2021 in Review

Fairpointe Capital increased its CONMED (CNMD) stake by 0.33% in Q1 2021, buying an estimated $1.08K and bringing the position to 2,715 shares worth $355K. The position accounts for 0.54% of the portfolio, ranked #52.

Fairpointe Capital first reported a position in CNMD in Q3 2020 and has held it in 3 quarters since. 239 funds tracked by Wall St. Rank hold CNMD as of Q1 2021.

  • Fairpointe Capital held 2,715 shares of CONMED worth $355K as of Q1 2021.
  • Fairpointe Capital bought 9 CONMED shares in Q1 2021, an estimated $1.08K.
  • CONMED made up 0.54% of Fairpointe Capital's portfolio in Q1 2021, its #52 holding.
  • Fairpointe Capital first reported a position in CONMED in Q3 2020 and has held it in 3 quarters since.
  • 239 funds tracked by Wall St. Rank held CONMED as of Q1 2021.

Based on Fairpointe Capital's 13F filing for Q1 2021, filed 13 May 2021.